Adverse events with pemigatinib in the real world: a pharmacovigilance study based on the FDA Adverse Event Reporting System
Article in Expert Opinion on Drug Safety (April 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Expert Opinion on Drug Safety (April 2024)
Article in Drug Safety (February 2024)
Article in Expert Opinion on Drug Safety (December 2023)